Drug · DIN 02439123
PROLENSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 25, 2015; first marketed September 25, 2015.
- Drug Identification Number (DIN)
- 02439123
- Company (DIN owner)
- Bausch & Lomb Inc.Rochester, New York, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Bromfenac S01BC11
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE) | 0.07 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 26, 2015: NOC 16727New Drug Submission (NDS)